Stem Cell Reports, 2014 · DOI: http://dx.doi.org/10.1016/j.stemcr.2014.06.018 · Published: August 7, 2014
Researchers investigated the effectiveness of CRISPR technology in axolotls, known for their regenerative abilities, by knocking out the Sox2 gene, important for neural stem cells. Deleting Sox2 during early development didn't prevent the axolotls from developing a normal spinal cord. However, these axolotls struggled to regenerate their spinal cord after tail amputation because neural stem cells didn't proliferate properly. The study also found that Sox3, a related gene, might compensate for the loss of Sox2 during development but not during regeneration, explaining why the axolotls could develop normally but not regenerate their spinal cords effectively.
CRISPRs are a superior method for genomic editing in axolotls, enhancing the study of gene function during regeneration.
Sox2 is crucial for neural stem cell proliferation during spinal cord regeneration, but not for initial development, providing a target for enhancing regeneration.
Sox3 compensates for Sox2 loss during development, suggesting potential therapeutic strategies focused on modulating Sox3 expression to improve regeneration outcomes.